pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 48 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 3
    bevacizumab
    Avastin (bevacizumab)
    Melanoma F. Hoffmann-La Roche Ltd5 cat
  • Phase 3
    ranibizumab biosimilar
    Cimerli (RANIBIZUMAB-EQRN)
    Wet (Neovascular / Exudative) Macular Degeneration Lupin Ltd5 cat
  • Phase 3
    dexamethasone acetate
    dexamethasone acetate
    Ocular Inflammation$OCS Oculis Holding AG1 cat
← prev
page 1 of 2
next →
131
Pain89
Neurology1
Phase 3
(neltependocel + Y-27632)
Vyznova (neltependocel [INN])
Corneal Edema
Aurion Biotech Inc
  • Phase 3
    (riboflavin + sodium iodide)
    (riboflavin [INN] + sodium iodide [USP])
    Keratoconus Epion Therapeutics Inc
  • Phase 3
    4D-150
    Wet (Neovascular / Exudative) Macular Degeneration$FDMT 4D Molecular Therapeutics, Inc.
  • Phase 3
    ATSN-201
    Unspecified Ophthalmological Disorders Atsena Therapeutics Inc
  • Phase 3
    AVD-104
    Dry (Atrophic) Macular Degeneration Aviceda Therapeutics Inc
  • Phase 3
    BRM-421
    Keratoconjunctivitis Sicca (Dry Eye) BRIM Biotechnology Inc
  • Phase 3
    ENB-106
    Diabetic Retinopathy Ennovabio
  • Phase 3
    K-161
    Keratoconjunctivitis Sicca (Dry Eye) Kowa Co Ltd
  • Phase 3
    OCU-410ST
    Juvenile Macular Degeneration (Stargardt Disease)$OCGN Ocugen, Inc.
  • Phase 3
    OPGx-LCA5
    Leber Congenital Amaurosis (LCA)$IRD Opus Genetics, Inc.
  • Phase 3
    PL-9643
    Keratoconjunctivitis Sicca (Dry Eye)$PTNT PALATIN TECHNOLOGIES INC
  • Phase 3
    Pollinex Quattro Grass
    Pollinex
    Allergic Rhino-Conjunctivitis Allergy Therapeutics Plc
  • Phase 3
    RTX-015
    Retinitis Pigmentosa (Retinitis) Ray Therapeutics Inc
  • Phase 3
    atropine
    atropine [USP]
    Myopia Ocumension Therapeutics Co Ltd
  • Phase 3
    baluretgene parvec
    baluretgene parvec
    Retinitis Pigmentosa (Retinitis)$OCGN Ocugen, Inc.
  • Phase 3
    bimatoprost grenod
    bimatoprost grenod
    Ocular Hypertension Kowa Co Ltd
  • Phase 3
    botaretigene sparoparvovec
    botaretigene sparoparvovec
    Retinitis Pigmentosa (Retinitis) Johnson & Johnson Innovative Medicine
  • Phase 3
    brolucizumab
    Beovu (brolucizumab)
    Proliferative Diabetic Retinopathy (PDR)$NVS NOVARTIS AG
  • Phase 3
    dazdotuftide
    dazdotuftide [INN]
    Anterior Uveitis Tarsier Pharma Ltd
  • Phase 3
    dexamethasone sodium phosphate
    SEMDEXA (dexamethasone sodium phosphate)
    Ataxia-Telangiectasia (Louis-Bar Syndrome)$QNCX Quince Therapeutics, Inc.
  • Phase 3
    elegrobart
    elegrobart
    Graves' Ophthalmopathy Viridian Therapeutics Inc
  • Phase 3
    emixustat hydrochloride
    emixustat hydrochloride
    Juvenile Macular Degeneration (Stargardt Disease) Kubota Vision Inc
  • Phase 3
    gildeuretinol acetate
    gildeuretinol acetate
    Juvenile Macular Degeneration (Stargardt Disease) Alkeus Pharmaceuticals Inc
  • Phase 3
    ixoberogene soroparvovec
    ixoberogene soroparvovec
    Wet (Neovascular / Exudative) Macular Degeneration Adverum Biotechnologies Inc
  • Phase 3
    laruparetigene zovaparvovec
    laruparetigene zovaparvovec
    Retinitis Pigmentosa (Retinitis) Beacon Therapeutics Ltd
  • Phase 3
    lenadogene nolparvovec
    LUMEVOQ (lenadogene nolparvovec [INN])
    Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) GenSight Biologics SA
  • Phase 3
    licaminlimab
    licaminlimab
    Keratoconjunctivitis Sicca (Dry Eye)$OCS Oculis Holding AG